DRMA

Dermata Therapeutics, Inc. DRMA

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode DRMA ATXI WINT CARM PBM LIPO VRAX ELAB GTBP REVB
6M 222.58 % 125.89 % -93.49 % -90.93 % -80.88 % -87.87 % -50.88 % -68.45 % -73.46 % -60.71 %
YTD 56.83 % -65.03 % -99.78 % -90.91 % -93.75 % -93.71 % -82.35 % -96.26 % -72.47 % -97.21 %
1Y 77.24 % -62.51 % -99.77 % -89.69 % -94.54 % -93.55 % -79.69 % -96.44 % -71.20 % -93.94 %
3Y -94.90 % -99.31 % -100.00 % -99.60 % -99.98 % -99.44 % -93.22 % -99.99 % -97.59 % -99.99 %
5Y -99.82 % -99.99 % -100.00 % -99.84 % -99.98 % -96.52 % -99.79 % -99.99 % -99.68 % -100.00 %
10Y -99.82 % -99.99 % -100.00 % -99.93 % -99.98 % -96.52 % -99.79 % -99.99 % -100.00 % -100.00 %
Depuis le début -99.82 % -99.99 % -100.00 % -99.98 % -99.98 % -96.52 % -99.79 % -99.99 % -100.00 % -100.00 %

Dividende

Carisma Therapeutics, Inc.